Genovate Biotechnology Co (ROCO:4130) Total Liabilities : NT$137.0 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Genovate Biotechnology Co Total Liabilities?

Genovate Biotechnology Co's Total Liabilities for the quarter that ended in Mar. 2024 was NT$137.0 Mil.

Genovate Biotechnology Co's quarterly Total Liabilities declined from Sep. 2023 (NT$152.14 Mil) to Dec. 2023 (NT$131.69 Mil) but then increased from Dec. 2023 (NT$131.69 Mil) to Mar. 2024 (NT$136.99 Mil).

Genovate Biotechnology Co's annual Total Liabilities increased from Dec. 2021 (NT$136.65 Mil) to Dec. 2022 (NT$153.60 Mil) but then declined from Dec. 2022 (NT$153.60 Mil) to Dec. 2023 (NT$131.69 Mil).

Genovate Biotechnology Co Total Liabilities Historical Data

The historical data trend for Genovate Biotechnology Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genovate Biotechnology Co Total Liabilities Chart

Genovate Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

164.68

144.87

136.65

153.60

131.69

Genovate Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															150.49	141.33	152.14	131.69	136.99

Genovate Biotechnology Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Genovate Biotechnology Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	117.726	+	(0.018	+	13.942
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	131.7

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1600.456	-	1468.77
	=	131.7

Genovate Biotechnology Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	130.744	+	(0	+	6.248
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	137.0

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1627.814	-	1490.822
	=	137.0

Genovate Biotechnology Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Genovate Biotechnology Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Genovate Biotechnology Co (ROCO:4130) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovate Biotechnology Co Ltd (ROCO:4130) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.1, First Industrial Road, Hsin-Chu Industrial Zone, Guangdong Province, Hsin-Chu, TWN

Website

http://www.genovate-bio.com

Genovate Biotechnology Co Ltd develops, manufactures and markets pharmaceutical preparations, drug substances and intermediates. Its product line includes nervous system drugs, digestive system drugs and cardiovascular system drugs, among others. It also provides clinical trial services for various drugs.

Genovate Biotechnology Co (ROCO:4130) Headlines

No Headlines